CONSOLI, Agostino
 Distribuzione geografica
Continente #
NA - Nord America 14.068
AS - Asia 8.414
EU - Europa 8.157
SA - Sud America 1.096
Continente sconosciuto - Info sul continente non disponibili 981
AF - Africa 150
OC - Oceania 11
Totale 32.877
Nazione #
US - Stati Uniti d'America 13.731
SG - Singapore 3.252
CN - Cina 2.381
IT - Italia 1.342
UA - Ucraina 1.193
IE - Irlanda 1.124
RU - Federazione Russa 969
TR - Turchia 953
BR - Brasile 869
GB - Regno Unito 846
SE - Svezia 777
FR - Francia 727
VN - Vietnam 665
DE - Germania 546
IN - India 345
FI - Finlandia 280
BD - Bangladesh 200
CA - Canada 176
HK - Hong Kong 156
AR - Argentina 80
PL - Polonia 72
MX - Messico 70
NL - Olanda 66
KR - Corea 65
JP - Giappone 60
EC - Ecuador 50
IQ - Iraq 50
ZA - Sudafrica 46
ID - Indonesia 45
ES - Italia 43
CZ - Repubblica Ceca 30
BE - Belgio 28
SA - Arabia Saudita 28
PH - Filippine 27
AT - Austria 25
CO - Colombia 24
EG - Egitto 23
PK - Pakistan 23
CL - Cile 22
IL - Israele 20
MY - Malesia 18
CR - Costa Rica 17
KE - Kenya 17
MA - Marocco 17
VE - Venezuela 17
EU - Europa 16
HN - Honduras 16
LT - Lituania 16
AE - Emirati Arabi Uniti 14
JM - Giamaica 14
UZ - Uzbekistan 14
DZ - Algeria 13
JO - Giordania 13
PY - Paraguay 12
RO - Romania 12
IR - Iran 10
PE - Perù 10
AU - Australia 9
BG - Bulgaria 9
CH - Svizzera 9
EE - Estonia 9
ET - Etiopia 9
KZ - Kazakistan 9
NP - Nepal 9
GT - Guatemala 8
PT - Portogallo 8
AZ - Azerbaigian 7
BO - Bolivia 7
DO - Repubblica Dominicana 7
TN - Tunisia 7
AL - Albania 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
TW - Taiwan 6
BH - Bahrain 5
NI - Nicaragua 5
OM - Oman 5
SN - Senegal 5
UY - Uruguay 5
GR - Grecia 4
LB - Libano 4
PS - Palestinian Territory 4
AM - Armenia 3
BB - Barbados 3
KG - Kirghizistan 3
KH - Cambogia 3
LK - Sri Lanka 3
NG - Nigeria 3
PA - Panama 3
RS - Serbia 3
BS - Bahamas 2
DK - Danimarca 2
HU - Ungheria 2
KW - Kuwait 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
QA - Qatar 2
SC - Seychelles 2
SV - El Salvador 2
XK - ???statistics.table.value.countryCode.XK??? 2
Totale 31.887
Città #
Singapore 2.267
San Jose 1.663
Jacksonville 1.359
Chandler 1.297
Dublin 1.115
Ashburn 843
Council Bluffs 581
Dallas 564
Southend 556
Princeton 539
Beijing 524
Izmir 499
Nanjing 383
Dearborn 376
Los Angeles 356
Wilmington 253
Santa Clara 242
Cambridge 223
Ho Chi Minh City 206
Buffalo 190
Tongling 188
The Dalles 164
New York 161
Hanoi 158
Nanchang 148
Ann Arbor 145
Hong Kong 142
Altamura 140
Moscow 134
Boardman 118
Pescara 115
Phoenix 107
Chieti 99
Shenyang 99
São Paulo 92
Woodbridge 91
Rome 88
Munich 74
Brooklyn 68
Hebei 68
Milan 68
Washington 66
Kunming 64
Grevenbroich 61
Tianjin 61
Jiaxing 56
Tokyo 54
Atlanta 53
Hefei 52
Norwalk 52
Columbus 48
Warsaw 48
Frankfurt am Main 47
Redondo Beach 47
Orem 46
Seoul 46
Chicago 44
Denver 44
Toronto 44
Kimball 42
Changsha 40
Houston 40
London 40
Montreal 38
San Francisco 38
Hangzhou 37
Helsinki 36
Chennai 35
Ningbo 32
Cedar Knolls 31
Haiphong 29
Nuremberg 29
Johannesburg 28
Rio de Janeiro 28
Falls Church 27
Mexico City 27
Orange 27
Stockholm 27
Jinan 26
Naples 26
Boston 23
Brussels 23
Dong Ket 23
Guangzhou 23
Brno 22
Manchester 22
Poplar 22
Da Nang 21
Silver Spring 20
Biên Hòa 19
San Mateo 19
Amsterdam 18
Augusta 18
Turku 18
Belo Horizonte 17
Mumbai 17
Quito 17
Seattle 17
Ankara 16
Changchun 16
Totale 18.510
Nome #
Policaptil Gel Retard® reduces body weight and improves insulin sensitivity in obese subjects 299
Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6 296
Old and New Biomarkers Associated with Endothelial Dysfunction in Chronic Hyperglycemia 290
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial 258
Vitamin E supplementation normalizes LDL susceptibility to oxidation in well controlled uncomplicated type II diabetes mellitus 211
Effects of a "single-meal" low calorie diet on the circadian variation of serum cortisol, insulin and somatotropin and urinary excretion of catecholamines. 207
Adherence of Uremic Erythrocytes to Vascular Endothelium decreases Endothelial Nitric Oxide Synthase Expression 203
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 202
A comparative safety review between GLP-1 receptor agonists and SGLT2 inhibitors for diabetes treatment 199
Principi di Endocrinologia 198
Postprandial hyperglycemia is a determinant of platelet activation in early type 2 diabetes mellitus 197
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trial. 192
Mechanisms of uremic erytrocyte-induced adhesion of human monocytes to cultured endothelial cells 189
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 183
Centella Asiatica inhibits TNFα-induced adhesion molecule expression in endothelial cells of umbilical cords from gestational diabetic women. 180
Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: association with increased nitric oxide synthase expression and superoxide anion generation. 168
Insulin enhances vascular adhesion molecule (VCAM-1) expression in human cultured endothelial cells through a pro-atherogenic p38MAP-kinase mediated pathway. 166
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 166
Il trattamento con Metformina riduce i livelli di alcuni indicatori di stress ossidativi in diabetici di tipo 2 164
Arterial wall and liver of diabetic rats exhibit increased synthesis of plasminogen activator inhibitor-1 (PAI-1). 164
ENPP1 Q121 variant, increased pulse pressure and reduced insulin signaling, and nitric oxide synthase activity in endothelial cells. Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1678-83. 164
Plasma exosome microRNA profiling unravels a new potential modulator of adiponectin pathway in diabetes: effect of glycemic control 164
Relationship between patient-practice oriented knowledge and metabolic control in intensively treated Type 1 diabetic patient: Result of the validation of the knowledge and Practices Diabetes Questionnaire 163
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity. 163
Assorbimento dell’insulina umana semisintetica dopo iniezione sottocutanea a spruzzo transcutaneo mediante iniettore 162
Oral Semaglutide in Routine Clinical Practice: Characteristics of People with Type 2 Diabetes Started on the Drug and Changes in Their Clinical Parameters after 24 Weeks of Treatment 161
Acute hyperglycemia and acute hyperinsulinemia both decrease plasma fibrinolytic activity and increase plasminogen activator type-1 (PAI-1) in the rat. 161
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 161
Obesity modifies the effects of the Asp905Tyr variant of PPP1R3A on risk of type 2 diabetes and insulin sensitivity 161
Difetti Beta cellulari nel diabete di tipo 2 153
Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes 153
Cigarette smoke, ferritin, and lipid peroxidation 152
Decreased in vivo oxidative stress and decreased platelet activation following metformin treatment in newly diagnosed type 2 diabetes subjects 151
Inositol and antioxidant supplementation: Safety and efficacy in pregnancy 151
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 150
Liraglutide mitigates TNF-alfa induced pro-atherogenic changes and microvesicle release in HUVEC from diabetic women 149
Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study 148
An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction. 147
Preliminari esperienze terapeutiche del diabete in gravidanza 147
MicroRNA profiling reveals new potential modulators of insulin-resistance and cardiovascular risk in type 2 diabetes 147
Effects of Liraglutide on Weight Loss, Fat Distribution, and β-Cell Function in Obese Subjects With Prediabetes or Early Type 2 Diabetes 147
Transmural distribution of antioxidant defences and lipid peroxidation in the rabbit left ventricular myocardium 146
A high-score Mediterranean dietary pattern is associated with a reduced risk of peripheral arterial disease in Italian patients with Type 2 diabetes 146
Circulating dickkopf-1 in diabetes mellitus: association with platelet activation and effects of improved metabolic control and low-dose aspirin. 146
[Type 2 diabetes treatment and cardiovascular risk: what can we learn from trials?] 146
Myoinositol reduces inflammation and oxidative stress in human endothelial cells exposed in vivo to chronic hyperglycemia 146
Iperespressione dell'inibitore dell'attivatore del plasminogeno di tipo 1 (PAI-1) nel fegato e nella aorta di ratti diabetici 144
Treatment of unstable diabetes by continuous subcutaneous infusion of insulin. 144
Thromboxane-dependent platelet activation in obese subjects with prediabetes or early type 2 diabetes: Effects of liraglutide-or lifestyle changes-induced weight loss 144
DHEA mimics acute actions of insulin to stimulate production of both NO and ET-1 via distinct PI 3-kinase- and MAP-kinase-dependent pathways in vascular endothelium. 144
Chronic in vivo hyperglycaemia increases nitroxidant stress and hinders nitric oxide availability in human vessels and human endothelial cells 143
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) regulates endothelial nitric oxide synthase (eNOS) activity and its localization within the human vein endothelial cells (HUVEC) in culture. 142
Blood sugar control in diabetic patients bearing microinfusors: the importance of the dawn phenomenon 142
TRIB3 R84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells. 142
Deletion of Gly723 in the insulin receptor substrate-1 of a patient with noninsulin-dependent diabetes mellitus. 142
Plasminogen Activator Inhibitor-1 synthesis is increased in arterial wall of diabetic subjects 141
Heightened free radical activity in angina pectoris 141
Valutazione del fabbisogno insulinico post-prandiale in pazienti diabetici trattati con microinfusore insulinico 140
Transcriptome analysis of human primary endothelial cells (HUVEC) from umbilical cords of Gestational Diabetic mothers reveals candidate sites for an epigenetic modulation of specific gene expression. 139
Liraglutide and cardiovascular outcomes in type 2 diabetes 139
Phenylmethimazole reverses plasminogen activator inhibitor-1 (PAI-1) overexpression in diabetic rats 137
Endocrinologia Clinica 137
Semaglutide and cardiovascular outcomes in patients with type 2 diabetes 137
Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. 136
I livelli di inibitore dell’attivatore del plasminogeno-1 (PAI-1) risultano aumentati nella parete arteriosa di pazienti diabetici 136
MicroRNA profiling reveals new potential modulators of insulin-resistance in type 2 Diabetes 136
Post-prandial requirement and composition of the diet. Study on type I diabetics treated with infuser 135
Ottimizzazione della terapia con insulina basale nel DM2: add-on di GLP-1 RA in associazione libera e in combinazione pre-costituita 135
Teleretinography into diabetes integrated care: an Italian experience 134
Selective insulin resistance affecting nitric oxide release but nor plasminogen activator inhibitor-1 synthesis in fibroblast from insulin-resistant individuals. 133
Administration of semisynthetic human insulin by a spray injector 133
Decreased expression of the plasminogen activator inhibitor-1 (PAI-1) gene in diabetic rats treated with phenylmethimazole 132
Variations in carbohydrate, lipid and protein oxidation evaluated by indirect calorimetry in obese subjects on a "single-meal" low-calorie diet. 132
Distribuzione transmurale dei sistemi antiossidanti e della perossidazione lipidica nel ventricolo sinistro di coniglio 132
Acute hyperinsulinemia decreases plasma fibrinolytic activity in the rat 132
Il sintomo impotenza come esordio di una neuropatia diabetica nel paziente di sesso maschile 131
Plasminogen activator inhibitor type 1 is increased in the arterial wall of type 2 diabetic subjects 131
Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance. 131
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 130
Extracellular vesicles number and cell subtype may be influenced by diabetes mellitus and metformin in patients at high cardiovascular risk 130
Valutazione dell’efficacia delle prestazioni nel servizio di diabetologia: impatto dell’emoglobina glicata 129
Le terapie incretiniche e l'approccio clinico multifattoriale del paziente cardiometabolico 129
Phenotyping normal kidney function in elderly patients with type 2 diabetes: a cross-sectional multicentre study 129
Soluble RAGE in type 2 diabetes: association with oxidative stress. 128
Combined effect of glucose and insulin in stimulating plasminogen activator inhibitor-1 secretion and gene expression in human vascular smooth muscle cells in culture 128
The dawn phenomenon in Type I (insulin-dependent) diabetic patient treated by continuous subcutaneous insulin infusion. 127
La terapia insulinica: tradizione e novità 127
Effectiveness and Tolerability of Once-Weekly GLP-1 Receptor Agonists in Clinical Practice: A Focus on Switching Between Once-Weekly Molecules in Type 2 Diabetes 126
Coagulation of hexokinase II and glycogen synthase RNA, protein, and activity in human muscle 126
La dieta ipocalorica nella terapia del diabete di tipo 2 con obesità. Confronto con dieta ipo- e normoglicidica a differente contenuto calorico. 126
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 126
The C242T polymorphism of the p22phox component of NAD(P)H oxidase and vascular risk. Two case-control studies and a meta-analysis. 125
MicroRNA profiling reveals new potetial modulators of insulin resistance and cardiovascular risk in type 2 diabetes 125
[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018] 125
Increased Plasminogen Activator Inhibitor (PAI-1) Synthesis and Gene Expression in Adipocyte of Diabetic Rats 124
Determinanti del controllo metabolico in pazienti con diabete di tipo I in terapia insulinica intensiva 124
Both acute and chronic hyperglycemia decrease plasma fribrinolytic activity in the rat. 124
Protective effects of glucagon-like peptide-1 on beta-cells: preclinical and clinical data. 124
Decreased plasma levels of soluble receptor for advanced glycation end products in type 2 diabetes mellitus: association with oxidative stress and metabolic control. 123
Treatment of brittle diabetes by continuous subcutaneous in-insulin infusion. Comparison with conventional treatment 122
Totale 15.291
Categoria #
all - tutte 131.139
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 131.139


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.136 0 0 0 247 93 19 50 79 107 36 157 348
2022/20233.707 325 403 196 435 324 758 233 288 493 54 116 82
2023/20241.883 111 61 135 69 74 497 474 78 26 79 63 216
2024/20254.409 336 694 507 99 94 138 159 277 571 186 463 885
2025/202610.004 770 507 1.069 1.146 848 608 1.513 654 1.149 869 543 328
2026/20272.564 520 764 546 734 0 0 0 0 0 0 0 0
Totale 32.877